Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
January 7, 2014
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens
Richard A Becker, Sean M Hays, Christopher R Kirman, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 15, 2016
Biomonitoring Equivalents for molybdenum
Sean M Hays, Kristin Macey, Devika Poddalgoda, et al.
Journal of Exposure Science & Environmental Epidemiology
|
May 17, 2012
Interpreting variability in population biomonitoring data: role of elimination kinetics
Lesa L Aylward, Chris R Kirman, John L Adgate, et al.
Journal of Exposure Science & Environmental Epidemiology
|
October 13, 2011
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria
Christopher R Kirman, Lesa L Aylward, Ben C Blount, et al.
International Journal of Hygiene and Environmental Health
|
June 11, 2016
Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context
Lesa L Aylward, Gerald Bachler, Natalie von Goetz, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 17, 2022
Best practices for exposure model peer review - A SciPinion advisory panel report
Sean M Hays, Christopher R Kirman, Jeffrey H Driver, et al.
Journal of Exposure Science & Environmental Epidemiology
|
June 25, 2009
Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004
Judy S LaKind, Daniel Q Naiman, Sean M Hays, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2011
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99)
Kannan Krishnan, Therese Adamou, Lesa L Aylward, et al.
Journal of Exposure Science & Environmental Epidemiology
|
December 7, 2018
Exposure to selected preservatives in personal care products: case study comparison of exposure models and observational biomonitoring data
Lesa Aylward, Giulia Vilone, Christina Cowan-Ellsberry, et al.
Critical Reviews in Toxicology
|
June 9, 2026
Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: input from an independent expert panel to support derivation of data-derived extrapolation factors
Christopher R Kirman, John C Lipscomb, John Rogers, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
January 7, 2014
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens
Richard A Becker, Sean M Hays, Christopher R Kirman, et al.
Regulatory Toxicology and Pharmacology : RTP
|
March 15, 2016
Biomonitoring Equivalents for molybdenum
Sean M Hays, Kristin Macey, Devika Poddalgoda, et al.
Journal of Exposure Science & Environmental Epidemiology
|
May 17, 2012
Interpreting variability in population biomonitoring data: role of elimination kinetics
Lesa L Aylward, Chris R Kirman, John L Adgate, et al.
Journal of Exposure Science & Environmental Epidemiology
|
October 13, 2011
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria
Christopher R Kirman, Lesa L Aylward, Ben C Blount, et al.
International Journal of Hygiene and Environmental Health
|
June 11, 2016
Biomonitoring Equivalents for interpretation of silver biomonitoring data in a risk assessment context
Lesa L Aylward, Gerald Bachler, Natalie von Goetz, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 17, 2022
Best practices for exposure model peer review - A SciPinion advisory panel report
Sean M Hays, Christopher R Kirman, Jeffrey H Driver, et al.
Journal of Exposure Science & Environmental Epidemiology
|
June 25, 2009
Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004
Judy S LaKind, Daniel Q Naiman, Sean M Hays, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2011
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99)
Kannan Krishnan, Therese Adamou, Lesa L Aylward, et al.
Journal of Exposure Science & Environmental Epidemiology
|
December 7, 2018
Exposure to selected preservatives in personal care products: case study comparison of exposure models and observational biomonitoring data
Lesa Aylward, Giulia Vilone, Christina Cowan-Ellsberry, et al.
Critical Reviews in Toxicology
|
June 9, 2026
Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: input from an independent expert panel to support derivation of data-derived extrapolation factors
Christopher R Kirman, John C Lipscomb, John Rogers, et al.
Page
of 9